Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8377933 | GILEAD | Method for treating a pulmonary hypertension condition |
Dec, 2027
(3 years from now) | |
US9474752 | GILEAD | Method for treating a pulmonary hypertension condition |
Dec, 2027
(3 years from now) | |
US9549926 | GILEAD | Compositions and methods of treating pulmonary hypertension |
Oct, 2031
(7 years from now) |
Drugs and Companies using AMBRISENTAN ingredient
Market Authorisation Date: 15 June, 2007
Treatment: For the treatment of pulmonary hypertension (pah) in combination with tadalafil; For the treatment of pulmonary arterial hypertension (pah) in combination with tadalafil, wherein the weight ratio of a...
Dosage: TABLET;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9744181 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(2 months ago) | |
US8592397 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(2 months ago) | |
US9457036 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(2 months ago) | |
US8716264 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(2 months ago) |
Drugs and Companies using EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE ingredient
Market Authorisation Date: 02 August, 2004
Treatment: Treatment of hiv infection; Treatment of hiv; Method of treatment of adults infected with hiv-1; Treatment of hiv-1 infection in pediatric patients 12 years of age and older
Dosage: TABLET;ORAL